A study presented on Feb. 6 at the American Stroke Association’s International Stroke Conference finds that stroke survivors who take cilostazol in combination with aspirin or clopidogrel have less risk of a recurrent stroke compared with those who take aspirin or clopidogrel alone.Read more via American Heart Association Newsroom.
Cilostazol, in combination with aspirin or clopidogrel, reduces risk for recurrent stroke
Share
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
